GRI · NASDAQ
GRI Bio (GRI) Stock Price & Fundamentals
GRI Bio (GRI) closed at $865.91 on Oct 9, 2026, up 0.90% from the previous close of $858.21.
Share price, past year
1Y +8.04%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $865.91 |
| Sep 30, 2026 | $886.76 |
| Aug 31, 2026 | $953.00 |
| Jul 31, 2026 | $1,006.99 |
| Jun 30, 2026 | $1,013.37 |
| May 29, 2026 | $1,009.38 |
| Apr 30, 2026 | $956.07 |
| Mar 31, 2026 | $999.04 |
| Feb 27, 2026 | $930.07 |
| Jan 30, 2026 | $875.85 |
| Dec 31, 2025 | $900.58 |
| Nov 28, 2025 | $883.20 |
| Oct 31, 2025 | $860.52 |
Key statistics
- Market cap
- $1.89B
- P/E (TTM)
- 11.6
- EPS (TTM)
- $74.70
- Revenue (TTM)
- —
- Net income (TTM)
- −$9.66M
- Shares outstanding
- 2.2M
- Dividend yield
- —
- 52-week range
- $800.51 – $1,048.40
GRI Bio's market cap is $1.89B, based on a share price of $865.91 and 2.2M shares outstanding as of Jun 30, 2026.
Financials
GRI Bio reported revenue of $0.00 for fiscal 2021, down 100.00% from fiscal 2020.
GRI Bio reported a net loss of $11.96M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2021ended Dec 31, 2021 | $0.00 | −100.0% | −$9.30M | — | −$20,314.15 | −$8.31M |
| FY2020ended Dec 31, 2020 | $100.00K | — | −$4.82M | −4,822.0% | −$15,307.14 | −$3.71M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2022ended Mar 31, 2022 | $0.00 | — | — |
| Q4 FY2021ended Dec 31, 2021 | $0.00 | — | — |
| Q3 FY2021ended Sep 30, 2021 | $0.00 | — | — |
| Q2 FY2021ended Jun 30, 2021 | $0.00 | — | — |
| Q1 FY2021ended Mar 31, 2021 | $0.00 | — | — |
| Q4 FY2020ended Dec 31, 2020 | $0.00 | — | — |
| Q3 FY2020ended Sep 30, 2020 | $0.00 | — | — |
| Q2 FY2020ended Jun 30, 2020 | $0.00 | — | — |
Company profile
- Name
- GRI Bio, Inc.
- Ticker
- GRI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2223 Avenida De La Playa, Suite 208, La Jolla, CA 92037
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001824293
Recent SEC filings
- Sep 8, 2026
- Aug 14, 2026
- Jun 18, 2026
- May 14, 2026
- May 13, 2026
- Feb 4, 2026
- Jan 30, 2026
- Jan 30, 2026
Frequently asked questions
What is GRI Bio's stock price?
GRI Bio (GRI) closed at $865.91 on Oct 9, 2026, up 0.90% from the previous close of $858.21.
What is GRI Bio's market cap?
GRI Bio's market cap is $1.89B, based on a share price of $865.91 and 2.2M shares outstanding as of Jun 30, 2026.
How much revenue does GRI Bio make?
GRI Bio reported revenue of $0.00 for fiscal 2021, down 100.00% from fiscal 2020.
What is GRI's P/E ratio?
GRI Bio's price-to-earnings ratio is 11.6, based on trailing twelve-month diluted EPS of $74.70.
Does GRI Bio pay a dividend?
GRI Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from GRI Bio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures